Home
HelpTest Code GAPCR Streptococcus Group A, Molecular Detection, PCR, Throat
Specimen Required
Patient Preparation: Do not collect throat swab specimens immediately after use of antiseptic mouthwash.
Specimen Type: Throat swab
Supplies: BD E-Swab (T853)
Container/Tube:
Preferred: BD Liquid Amies Elution Swab (ESwab)
Acceptable: Copan Liquid Amies Elution Swab (ESwab)
Specimen Volume: Entire collection/1 ESwab
Collection Instructions:
1. Must be collected and transported using the ESwab collection kit.
2. Using a tongue blade to hold the tongue down, firmly rub the swab over the tonsils, posterior pharynx, and any areas of inflammation with exudate. Ensure that areas with exudate or inflammation are swabbed.
3. Avoid the tongue, teeth, and gums as the swab is withdrawn.
4. Insert the swab back into the ESwab transport tube and break the swab at the indicated score line.
5. Label specimen according to policy.
6. Send refrigerated. Do not freeze.
Useful For
Detecting group A streptococcal infections in patients with signs and symptoms of pharyngitis using a throat swab specimen
The test is not intended for monitoring treatment for group A Streptococcus infections.
Method Name
Real-Time Polymerase Chain Reaction (PCR)
Reporting Name
Group A Streptococcus PCR, ThroatSpecimen Type
VariesSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Refrigerated (preferred) | 6 days | |
| Ambient | 48 hours |
Reject Due To
| Specimens collected in media other than ESwab collection kit | Reject |
Clinical Information
Group A streptococci are gram-positive, beta-hemolytic disease-causing bacteria that commonly cause infections in the throat (pharyngitis or strep throat) or on skin (cellulitis and impetigo) and can cause a wide range of other infections (eg, sepsis, pneumonia, and meningitis). Pharyngitis may also be caused by other bacteria, including Neisseria gonorrhoeae and Corynebacterium diphtheriae, for which specific culture methods are required. If left untreated, mild infections can lead to more serious infections. The most severe but least common forms of invasive Group A streptococcal disease (GAS) are necrotizing fasciitis and streptococcal toxic shock syndrome. Several million cases of strep throat and impetigo occur each year with approximately 9000 to 11,500 cases of invasive GAS disease occurring in the United States, resulting in 1000 to 1800 deaths.(1) Treating an infected person with an appropriate antibiotic generally prevents the spread of the infection and reduces the risk of post-infectious complications, such as rheumatic fever and acute glomerular nephritis.(2)
Reference Values
Negative
Interpretation
Positive: Streptococcus pyogenes DNA is detected.
Negative: Streptococcus pyogenes DNA is not detected.
Cautions
Additional follow-up testing by culture is required if the Xpert Xpress Strep A test result is negative and clinical symptoms persist or if there is an outbreak of acute rheumatic fever.
As with many diagnostic tests, negative results from the Xpert Xpress Strep A test do not preclude a Strep A infection and should not be used as the sole basis for treatment or other patient management decisions. The Xpert Xpress Strep A test does not differentiate asymptomatic carriers of Group A streptococci from those exhibiting streptococcal infection. The results from the Xpert Xpress Strep A test should be interpreted in conjunction with other laboratory and clinical data available to the clinician.
A negative test result does not exclude the possibility of infection because the test result may be affected by improper specimen collection, technical error, sample mix-up, or because the number of organisms in the sample is below the limit of detection of the test.(3)
Because the detection of Streptococcus pyogenes is dependent on the organism's DNA present in the sample, reliable results are dependent on proper specimen collection, handling, and storage.
The Xpert Xpress Strep A test has been validated only with Copan Liquid Amies Elution Swab (ESwab) Collection Kit (Copan 480C, Copan 480CE, or Copan 480CFA) or equivalent.
Variants or nucleotide alterations (ie, polymorphisms) in primer or probe binding regions may affect detection of new or unknown S pyogenes strains resulting in a false-negative result.
This test has not been evaluated for patients without signs and symptoms of pharyngitis.
This test cannot rule out pharyngitis caused by disease-causing organisms other than Group A streptococci.
The analyte target (bacterial nucleic acid) may persist in vivo, independent of pathogen viability. Detection of the analyte target does not imply that the corresponding pathogen is either infectious or is the causative agent of the clinical symptoms.(3)
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
87651
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| GAPCR | Group A Streptococcus PCR, Throat | 60489-2 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| GAPCR | Group A Streptococcus PCR, Throat | 60489-2 |